Publications by authors named "Nicola Bisogno"

Article Synopsis
  • SGLT2 inhibitors are increasingly used for managing diabetes and have additional benefits for kidney function and heart health.
  • Despite their advantages, they can cause complications like euglycemic ketoacidosis, which is a serious condition.
  • In a reported case, a 47-year-old patient developed ketoacidosis after 5 years on SGLT2 therapy, and successful resolution was achieved using somatostatin alongside standard treatment.
View Article and Find Full Text PDF